cryptosign10k06302015.htm

Exhibit 10.61

COMMON STOCK SUBSCRIPTION AGREEMENT

by and among

STRATEGABIZ, INC.

and

THE PURCHASERS NAMED ON SCHEDULE 1 HERETO

June __, 2015

NOTHING IN THIS DOCUMENT CONSTITUTES AN OFFER OF SECURITIES FOR SALE IN THE UNITED STATES OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO DO SO. THE SECURITIES DESCRIBED IN THE ATTACHED DOCUMENT HAVE NOT BEEN, AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OF THE U.S. OR OTHER JURISDICTION AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT (“REGULATION S”), EXCEPT PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND ANY APPLICABLE STATE OR LOCAL SECURITIES LAWS.

COMMON STOCK SUBSCRIPTION AGREEMENT

This COMMON STOCK SUBSCRIPTION AGREEMENT, dated as of June ___, 2015 (this “Agreement”), is by and among STRATEGABIZ, INC., a Delaware corporation (the “Company”), and the undersigned purchase or purchaser’s listed on one or more signature pages attached hereto (each a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, the Company desires to issue and sell to the Purchasers, and each Purchaser desires to purchase from the Company, certain shares of the Company’s common stock, par value $0.0001 per share (the “Common Shares”) in accordance with the provisions of this Agreement.

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein and for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and each of the Purchasers, severally and not jointly, hereby agree as follows:

ARTICLE I

DEFINITIONS

Section 1.1 Definitions. As used in this Agreement, and unless the context requires a different meaning, the following terms have the meanings indicated:

“Affiliate” means, with respect to any Person, any other Person that directly or indirectly through one or more intermediaries controls, is controlled by or is under common control with, the Person in question. As used herein, the term “control” means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through ownership of voting securities, by contract or otherwise.

“Agreement” has the meaning set forth in the introductory paragraph.

“Closing” has the meaning specified in Section 2.2.

“Closing Date” has the meaning specified in Section 2.2.

“Commission” means the United States Securities and Exchange Commission.

“Common Stock” has the meaning specified in Section 3.2.

“Company” has the meaning set forth in the introductory paragraph.

“Company Financial Statements” has the meaning specified in Section 3.9.

“Common Share Price” means $2.25.

“Common Shares” has the meaning specified in the recitals.

“Company SEC Documents” has the meaning specified in Section 3.8.

“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and the rules and regulations of the Commission promulgated thereunder.

“GAAP” has the meaning specified in Section 3.9.

“Governmental Authority” means, with respect to a particular Person, any country, state, county, city and political subdivision in which such Person or such Person’s Property is located or that exercises valid jurisdiction over any such Person or such Person’s Property, and any court, agency, department, commission, board, bureau or instrumentality of any of them and any monetary authority that exercises valid jurisdiction over any such Person or such Person’s Property. Unless otherwise specified, all references to Governmental Authority herein with respect to the Company mean a Governmental Authority having jurisdiction over the Company, its Subsidiaries or any of their respective Properties.

“Indemnified Party” has the meaning specified in Section 6.3.

“Indemnifying Party” has the meaning specified in Section 6.3.

“Law” means any federal, state, local or foreign order, writ, injunction, judgment, settlement, award, decree, statute, law, rule or regulation.

“Lien” means any interest in Property securing an obligation owed to, or a claim by, a Person other than the owner of the Property, whether such interest is based on the common law, statute or contract, and whether such obligation or claim is fixed or contingent, and including the lien or security interest arising from a mortgage, encumbrance, pledge, security agreement, conditional sale or trust receipt or a lease, consignment or bailment for security purposes. For the purpose of this Agreement, a Person shall be deemed to be the owner of any Property that it has acquired or holds subject to a conditional sale agreement, or leases under a financing lease or other arrangement pursuant to which title to the Property has been retained by or vested in some other Person in a transaction intended to create a financing.

“Material Adverse Effect” means a material adverse effect on the management, condition (financial or otherwise), results of operations, business or properties of the Company and its Subsidiaries, taken as a whole; provided, however, that a Material Adverse Effect shall not include any material and adverse effect on the foregoing to the extent such material and adverse effect results from, arises out of, or relates to (x) a general deterioration in the economy or changes in the general state of the industries in which the Company operates, except to the extent that the Company, taken as a whole, is adversely affected in a disproportionate manner as compared to other industry participants, (y) the outbreak or escalation of hostilities involving the United States, the declaration by the United States of a national emergency or war or the occurrence of any other calamity or crisis, including acts of terrorism, or (z) any change in accounting requirements or principles imposed upon the Company and its Subsidiaries or their respective businesses or any change in any applicable Law, or the interpretation thereof.

“Operative Documents” means, collectively, this Agreement and any amendments, supplements, continuations or modifications thereto.

“Person” means an individual or a corporation, limited liability company, partnership, joint venture, trust, unincorporated organization, association, government agency or political subdivision thereof or other form of entity.

“Preferred Stock” has the meaning specified in Section 3.2.

“Property” means any interest in any kind of property or asset, whether real, personal or mixed, or tangible or intangible.

“Purchase Price” is USD $2.25 per share.

“Purchased Shares” means, with respect to a particular Purchaser, the number of Common Shares set forth on the Purchaser’s signature page.

“Purchaser” and “Purchasers” have the meanings set forth in the introductory paragraph.

“Purchaser Related Parties” has the meaning specified in Section 6.1.

“Representatives” of any Person means the Affiliates, officers, directors, managers, employees, agents, counsel, accountants, investment bankers, investment advisers and other representatives of such Person.

“Securities Act” means the Securities Act of 1933, as amended from time to time, and the rules and regulations of the Commission promulgated thereunder.

“Short Sales” means, without limitation, all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act, whether or not against the box, and forward sale contracts, options, puts, calls, short sales, “put equivalent positions” (as defined in Rule 16a-1(h) under the Exchange Act) and similar arrangements, and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.

“Subsidiary” has the meaning set forth in Rule 405 of the rules and regulations promulgated under the Securities Act.

“U.S. Persons” as defined Rule 902(k)(1), which are (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administer is a U.S. person; (4) any trust or which any trustee is a U.S. person; (5) any agency or branch of a U.S. person located outside the United States; (6) any non-discretionary or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) a discretionary or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated or, if an individual, resident in the United States; and (8) an partnership or corporation if (a) organized or incorporated under the laws of any foreign jurisdiction, and (b) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated and owned by accredited investors under Rule 501(a) of the Securities Act who are not natural persons, estates or trusts.

ARTICLE II

AGREEMENT TO SELL AND PURCHASE

Section 2.1 Sale and Purchase. Subject to the terms and conditions hereof, the Company hereby agrees to issue and sell to each Purchaser and each Purchaser hereby agrees, severally and not jointly, to purchase from the Company, its respective Purchased Shares, and each Purchaser agrees, severally and not jointly, to pay the Company the Common Share Price for each Purchased Share.

Section 2.2 Closing. Pursuant to the terms of this Agreement, the consummation of the purchase and sale of the Purchased Shares hereunder (the “Closing”) shall take place at such time and place as the Company and Purchasers determine (the date of such closing, the “Closing Date”). The parties agree that the Closing may occur via delivery of facsimiles, electronic copies or photocopies of the Operative Documents and the closing deliverables contemplated hereby and thereby. Unless otherwise provided herein, all proceedings to be taken and all documents to be executed and delivered by all parties at the Closing will be deemed to have been taken and executed simultaneously, and no proceedings will be deemed to have been taken nor documents executed or delivered until all have been taken.

Section 2.3 Each Purchaser’s Conditions. The obligation of each Purchaser to consummate the purchase of its Purchased Shares shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions (any or all of which may be waived by a particular Purchaser on behalf of itself in writing with respect to its Purchased Shares, in whole or in part, to the extent permitted by applicable Law):

(a) the Company shall have performed and complied with the covenants and agreements contained in this Agreement that are required to be performed and complied with by the Company on or prior to the Closing Date;

(b) all representations and warranties of the Company shall be true and correct in all material respects when made and as of the Closing Date, in each case as though made at and as of the Closing Date (except that representations and warranties made as of a specific date shall be required to be true and correct as of such date only);

(d) the Company shall have delivered, or caused to be delivered, to such Purchaser at the Closing, the Company’s closing deliveries described in Section 2.5.

Section 2.4 Company’s Conditions. The obligation of the Company to consummate the issuance and sale of the Purchased Shares to each Purchaser shall be subject to the satisfaction on or prior to the Closing Date of each of the following conditions with respect to such Purchaser (any or all of which may be waived by the Company in writing, in whole or in part, to the extent permitted by applicable Law):

(a) the representations and warranties of such Purchaser contained in this Agreement that are qualified by materiality shall be true and correct when made and as of the Closing Date and all other representations and warranties of such Purchaser shall be true and correct in all material respects as of the Closing Date (except that representations of such Purchaser made as of a specific date shall be required to be true and correct as of such date only);

(b) such Purchaser shall have performed and complied with the covenants and agreements contained in this Agreement that are required to be performed and complied with by that Purchaser on or prior to the Closing Date; and

(c) such Purchaser shall have delivered, or caused to be delivered, to the Company at the Closing such Purchaser’s closing deliveries described in Section 2.6,

Section 2.5 Deliveries by the Company. Upon the terms and subject to the conditions of this Agreement, at the Closing, the Company will deliver (or cause to be delivered) the following:

(a) evidence of issuance of a certificate evidencing the Purchased, bearing the legend or restrictive notation set forth in Section 4.10, free and clear of any Liens, other than transfer restrictions under applicable federal and state securities laws; and

(b) a copy of the risk factors attached hereto as Exhibit A.

Section 2.6 Purchaser Deliveries. Upon the terms and subject to the conditions of this Agreement, each Purchaser is delivering (or causing to be delivered) the following:

(a) the Purchase Price payable by such Purchaser by wire transfer of immediately available funds;

Section 2.7 Independent Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Operative Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any other Purchaser under any Operative Document. Nothing contained herein or in any other Operative Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of group or entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Operative Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement or out of the other Operative Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. The failure or waiver of performance by any Purchaser does not excuse performance by any other Purchaser.

ARTICLE III

REPRESENTATIONS AND WARRANTIES OF THE COMPANY

The Company represents and warrants to each Purchaser as follows:

Section 3.1 Existence. The Company has been duly incorporated and is existing and in good standing under the laws of the State of Delaware, with corporate power and authority to own its properties and conduct the businesses in which it is currently engaged and the Company is duly qualified to do business as a foreign corporation in good standing in all other jurisdictions in which its ownership or lease of property or the conduct of its business requires such qualification, except where the failure to be duly qualified or in good standing would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.

Section 3.2 Capitalization. The authorized capital stock of the Company consists of 100,000,000 shares of common stock, par value $0.0001 per share (“Common Stock”) and four hundred thousand (400,000) shares of preferred stock (“Preferred Stock”), having a par value of $0.0001. As of the close of business on June 15, 2015, there were (i) 3,672,236 shares of Common Stock outstanding and (ii) no shares of Preferred Stock outstanding.

Section 3.3 Subsidiaries. The Company has no Subsidiaries.

Section 3.4 No Conflict. The execution, delivery and performance of this Agreement and the issuance and sale of the Purchased Shares will not result in a breach or violation of any of the terms and provisions of, or constitute, or with the giving of notice or lapse of time, would constitute, a default under, or result in the imposition of any lien, charge or encumbrance upon any property or assets of the Company pursuant to, (i) its certificate of formation, limited liability company agreement, limited partnership agreement, charter, or by-laws or similar organizational documents of the Company, (ii) any statute, rule, regulation or order of any governmental agency or body or any court, domestic or foreign, having jurisdiction over the Company or any of its properties, or (iii) any agreement or instrument to which the Company is a party or by which the Company or any of its Subsidiaries is bound or to which any of the properties of the Company or any of its Subsidiaries is subject, except in the case of clauses (ii) and (iii) as would not reasonably be expected to have a Material Adverse Effect.

Section 3.5 Authority.

(a) Each of the Operative Documents has been or will be validly executed and delivered by the Company and, assuming due authorization, execution and delivery by each Purchaser or its Affiliate, as applicable (if either such Purchaser or its Affiliate is a party thereto), constitutes, or will constitute, the legal, valid and binding obligations of the Company enforceable in accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization and other laws of general applicability relating to or affecting creditors’ rights and by general principles of equity.

(b) The Purchased Shares have been duly authorized and, when the Purchased Shares have been delivered and paid for in accordance with this Agreement on the Closing Date, such Purchased Shares will be validly issued, fully paid and nonassessable; the stockholders of the Company have no preemptive rights with respect to the Purchased Shares; and none of the outstanding shares of capital stock of the Company have been issued in violation of any preemptive or similar rights of any security holder. Except as described or disclosed in the Company SEC Documents there are no outstanding (A) securities or obligations of the Company

convertible into or exchangeable for any capital stock of the Company, (B) warrants, rights or options to subscribe for or purchase from the Company any such capital stock or any such convertible or exchangeable securities or obligations or (C) obligations of the Company to issue or sell any shares of capital stock, any such convertible or exchangeable securities or obligations or any such warrants, rights or options.

Section 3.6 Approvals. No consent, approval, authorization, or order of, or filing or registration with, any person (including any governmental agency or body or any court) is required to be obtained or made by the Company for the consummation of the transactions contemplated by this Agreement, except (i) such as have been obtained, (ii) where the failure of the Company to obtain or make any such consent, approval, authorization, order, filing or registration would not reasonably be expected to have a Material Adverse Effect, or (iii) such as have been made or as may be required under state or foreign securities laws.

Section 3.7 Compliance with Laws. Neither the Company nor any of its Subsidiaries is in violation of any Law applicable to the Company or its Subsidiaries, except as would not, individually or in the aggregate, have a Material Adverse Effect. The Company and its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except where the failure to possess such certificates, authorizations or permits would not, individually or in the aggregate, have a Material Adverse Effect, and neither the Company nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate, authorization or permit, except where such potential revocation or modification would not, individually or in the aggregate, have a Material Adverse Effect.

Section 3.8 Periodic Reports. All forms, registration statements, reports, schedules and statements required to be filed by the Company under the Exchange Act or the Securities Act (all such documents, including the exhibits thereto, prior to the date hereof, collectively the “Company SEC Documents”) have been filed with the Commission on a timely basis. The Company SEC Documents, including, without limitation, any audited or unaudited financial statements and any notes thereto or schedules included therein (the “Company Financial Statements”), at the time filed (or in the case of registration statements, solely on the dates of effectiveness) (except to the extent corrected by a subsequent Company SEC Document) (a) did not contain any untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading, (b) complied as to form in all material respects with the applicable requirements of the Exchange Act and the Securities Act, as the case may be, (c) complied as to form in all material respects with applicable accounting requirements and with the published rules and regulations of the Commission with respect thereto, (d) with respect to the Company Financial Statements, were prepared in accordance with GAAP applied on a consistent basis during the periods involved (except as may be indicated in the notes thereto or, in the case of unaudited statements, as permitted by Form 10-Q of the Commission), and (e) with respect to the Company Financial Statements, fairly present (subject in the case of unaudited statements to normal and recurring audit adjustments) in all material respects the consolidated financial position of the Company and its consolidated subsidiaries as of the dates thereof and the consolidated results of its operations and cash flows for the periods then ended. The Company’s auditor is an independent registered public accounting firm with respect to the Company and has not resigned or been dismissed as independent registered public accountants of the Company as a result of or in connection with any disagreement with the Company on any matter of accounting principles or practices, financial statement disclosure or auditing scope or procedures.

Section 3.9 Certain Fees. No fees or commissions are or will be payable by the Company to brokers, finders, or investment bankers with respect to the sale of any of the Purchased Shares or the consummation of the transaction contemplated by this Agreement. The Company agrees that it will indemnify and hold harmless the Purchaser from and against any and all claims, demands, or liabilities for broker’s, finder’s, placement, or other similar fees or commissions incurred by the Company in connection with the sale of the Purchased Shares or the consummation of the transactions contemplated by this Agreement.

Section 3.10 No Side Agreements. There are no agreements by, among or between the Company or any of its Affiliates, on the one hand, and any Purchaser or any of their Affiliates, on the other hand, with respect to the transactions contemplated hereby other than the Operative Documents nor promises or inducements for future transactions between or among any of such parties.

Section 3.11 No General Solicitation; No Advertising. The Company has not solicited offers for, or offered or sold, and will not solicit offers for, or offer or sell, the Securities by means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act

Section 3.12 No Registration Required. Assuming the accuracy of the representations and warranties of each Purchaser contained in Article IV, the issuance and sale of the Purchased Shares pursuant to this Agreement is exempt from registration requirements of the Securities Act, and neither the Company nor, to the knowledge of the Company, any authorized Representative acting on its behalf has taken or will take any action hereafter that would cause the loss of such exemption.

Section 3.13 No Integration. Neither the Company nor any of its Affiliates have, directly or indirectly through any agent, sold, offered for sale, solicited offers to buy or otherwise negotiated in respect of, any “security” (as defined in the Securities Act of 1933, as amended) that is or will be integrated with the sale of the Purchased Shares in a manner that would require registration under the Securities Act.

ARTICLE IV

REPRESENTATIONS AND WARRANTIES OF THE PURCHASERS

Each Purchaser, severally and not jointly, hereby represents and warrants to the Company that:

Section 4.1 Existence. Such Purchaser is duly organized and validly existing and in good standing under the Laws of its jurisdiction of organization, with all requisite power and authority to own, lease, use and operate its Properties and to conduct its business as currently conducted.

Section 4.2 Authorization, Enforceability. Such Purchaser has all necessary corporate, limited liability company or partnership power and authority to execute, deliver and perform its obligations under this Agreement and to consummate the transactions contemplated thereby, and the execution, delivery and performance by such Purchaser of this Agreement has been duly authorized by all necessary action on the part of such Purchaser; and this Agreement constitute the legal, valid and binding obligations of such Purchaser, enforceable in accordance with their terms, except as such enforceability may be limited by bankruptcy, insolvency, fraudulent transfer and similar laws affecting creditors’ rights generally or by general principles of equity, including principles of commercial reasonableness, fair dealing and good faith.

Section 4.3 No Breach. The execution, delivery and performance of this Agreement by such Purchaser and the consummation by such Purchaser of the transactions contemplated hereby and thereby will not (a) conflict with or result in a breach or violation of any of the terms or provisions of, or constitute a default under, any material agreement to which such Purchaser is a party or by which such Purchaser is bound or to which any of the property or assets of such Purchaser is subject, (b) conflict with or result in any violation of the provisions of the organizational documents of such Purchaser, or (c) violate any statute, order, rule or regulation of any court or governmental agency or body having jurisdiction over such Purchaser or the property or assets of such Purchaser, except in the cases of clauses (a) and (c), for such conflicts, breaches, violations or defaults as would not prevent the consummation of the transactions contemplated by this Agreement.

Section 4.4 Certain Fees. No fees or commissions are or will be payable by such Purchaser to brokers, finders, or investment bankers with respect to the purchase of any of the Purchased Shares or the consummation of the transaction contemplated by this Agreement. Such Purchaser agrees that it will indemnify and hold harmless the Company from and against any and all claims, demands, or liabilities for broker’s, finder’s, placement, or other similar fees or commissions incurred by such Purchaser in connection with the purchase of the Purchased Shares or the consummation of the transactions contemplated by this Agreement.

Section 4.5 No Side Agreements. There are no other agreements by, among or between such Purchaser and any of its Affiliates, on the one hand, and the Company or any of its Affiliates, on the other hand, with respect to the transactions contemplated hereby other than the Operative Documents nor promises or inducements for future transactions between or among any of such parties.

Section 4.6 Investment. The Purchased Shares are being acquired for such Purchaser’s own account, the account of its Affiliates, or the accounts of clients for whom such Purchaser exercises discretionary investment authority, not as a nominee or agent, and with no present intention of distributing the Purchased Shares or any part thereof, and such Purchaser has no present intention of selling or granting any participation in or otherwise distributing the same in any transaction in violation of the securities laws of the United States or any state or country, without prejudice, however, to such Purchaser’s right at all times to sell or otherwise dispose of all or any part of the Purchased Shares under a registration statement under the Securities Act and applicable state securities laws or under an exemption from such registration available thereunder (including, without limitation, if available, Rule 144 promulgated thereunder). If such Purchaser should in the future decide to dispose of any of the Purchased Shares, the Purchaser understands and agrees (a) that it may do so only in compliance with the Securities Act and applicable state securities law, as then in effect, including a sale contemplated by any registration statement pursuant to which such securities are being offered, or pursuant to an exemption from the Securities Act, and (b) that stop-transfer instructions to that effect will be in effect with respect to such securities.

Section 4.7 Nature of Purchaser.

(a) Purchaser is not a U.S. Person and is and is not acquiring the Shares for the account or benefit of any U.S. person or is a U.S. person who purchased the Shares in a transaction that did not require registration under the Securities Act. No “directed selling efforts” (as such term is defined under Rule 903 to Regulation S of the Securities Act) to the Purchase has been made within the United States.

(b) Such Purchaser or its Representatives have been furnished with materials relating to the business, finances and operations of the Company and relating to the offer and sale of the Purchased Shares that have been requested by such Purchaser. Such Purchaser or its Representatives has been afforded the opportunity to ask questions of the Company or its Representatives. Neither such inquiries nor any other due diligence investigations conducted at any time by such Purchaser or its Representatives shall modify, amend or affect such Purchaser’s right (i) to rely on the Company’s representations and warranties contained in Article III above or (ii) to indemnification or any other remedy based on, or with respect to the accuracy or inaccuracy of, or compliance with, the representations, warranties, covenants and agreements in this Agreement. Such Purchaser understands and acknowledges that its purchase of the Purchased Shares involves a high degree of risk and uncertainty. Such Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect to its investment in the Purchased Shares.

Section 4.8 Restricted Securities. Such Purchaser understands that the Purchased Shares are characterized as “restricted securities” under the federal securities Laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such Laws and applicable regulations such securities may be resold without registration under the Securities Act only in certain limited circumstances. In this connection, such Purchaser represents that it is knowledgeable with respect to Rule 144 of the Commission promulgated under the Securities Act. The Shares have not been registered under the Securities Act or the securities laws of any state of the United States and are subject to certain restrictions on transfer. The sale of the Purchased Shares are offered only to non-U.S. persons (within the meaning of Regulation S under the Securities Act) outside the United States under Regulation S under the Securities Act. We have not authorized its use for any other purpose. Such Purchaser understands that hedging transactions involving the purchased Shares may not be conducted unless in compliance with the Securities Act. In addition, the offer or sale of the Shares, if made prior to the expiration of the six month distribution compliance period, may not be made to a U.S. person or for the account or benefit of a U.S. person (other than a distributor); and the offer or sale, if made prior to the expiration of the six-month distribution compliance period, is made pursuant to the following conditions: (a) the purchaser certifies that it is not a U.S. person and is not acquiring the securities for the account or benefit of any U.S. person or is a U.S. person who purchased securities in a transaction that did not require registration under the Securities Act; and (b)the purchaser agrees to resell such securities only in accordance with the provisions of Regulation S, pursuant to registration under the Securities Act, or pursuant to an available exemption from registration; and agrees not to engage in hedging transactions with regard to such securities unless in compliance with the Securities Act

Section 4.9 Reliance Upon such Purchaser’s Representations and Warranties. Such Purchaser understands and acknowledges that the Purchased Shares are being offered and sold in reliance on a transactional exemption from the registration requirements of federal and state securities laws, and that the Company is relying in part upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of such Purchaser set forth in this Agreement in (i) concluding that the issuance and sale of the Purchased Shares is a “private offering” and, as such, is exempt from the registration requirements of the Securities Act, and (ii) determining the applicability of such exemptions and the suitability of such Purchaser to purchase the Purchased Shares.

Section 4.10 Legend; Restrictive Notation. Purchases of the Shares made in reliance upon Regulation S, will, until the expiration of a six month “distribution compliance period” within the meaning of Rule 903 of Regulation S with respect to the Shares. Purchaser understands that the certificates evidencing the Purchased Shares will bear the following legend or restrictive notation:

THIS SECURITY WILL BE OFFERED ONLY OUTSIDE OF THE UNITED STATES TO NON-U.S. PERSONS, PURSUANT TO THE PROVISIONS OF REGULATION S OF THE U.S. SECURITIES ACT OF 1933, AS AMENDED. THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (“SECURITIES ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION, AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR TO OR FOR THE ACCOUNT OR BENEFIT OF U.S. PERSONS EXCEPT AS SET FORTH IN THE FOLLOWING SENTENCE. BY ITS ACQUISITION HEREOF, THE HOLDER (1) REPRESENTS THAT IT IS NOT A U.S. PERSON, IS NOT ACQUIRING THIS SECURITY FOR THE ACCOUNT OR BENEFIT OF A U.S. PERSON AND IS ACQUIRING THIS SECURITY IN AN OFFSHORE TRANSACTION, (2) BY ITS ACCEPTANCE HEREOF, AGREES TO OFFER, SELL OR OTHERWISE TRANSFER SUCH SECURITY ONLY (A) TO THE ISSUER OR ANY AFFILIATE THEREOF, (B) PURSUANT TO A REGISTRATION STATEMENT THAT HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THE SECURITIES ARE ELIGIBLE FOR RESALE PURSUANT TO RULE 144A UNDER THE SECURITIES ACT (“RULE 144A”), TO A PERSON IT REASONABLY BELIEVES IS A “QUALIFIED INSTITUTIONAL BUYER” AS DEFINED IN RULE 144A THAT PURCHASES FOR ITS OWN ACCOUNT OR FOR THE ACCOUNT OF A QUALIFIED INSTITUTIONAL BUYER TO WHOM NOTICE IS GIVEN THAT THE TRANSFER IS BEING MADE IN RELIANCE ON RULE 144A IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE 144A, (D) PURSUANT TO OFFERS AND SALES THAT OCCUR OUTSIDE THE UNITED STATES IN COMPLIANCE WITH RULE 903 OR 904 UNDER REGULATION S UNDER THE SECURITIES ACT OR (E) PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT, SUBJECT TO THE RECEIPT BY THE ISSUER OF AN OPINION OF COUNSEL THAT SUCH SALE OR TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS OF THE STATES OF THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION, (3) AGREES THAT IT WILL DELIVER TO EACH PERSON TO WHOM THIS SECURITY IS TRANSFERRED A NOTICE SUBSTANTIALLY TO THE EFFECT OF THIS RESTRICTIVE LEGEND. THIS LEGEND WILL BE REMOVED AFTER SIX CONSECUTIVE MONTHS BEGINNING ON THE DAY ON WHICH THE SECURITIES ARE OFFERED TO PERSONS OTHER THAN DISTRIBUTORS (AS DEFINED IN REGULATION S UNDER THE SECURITIES ACT) AS USED HEREIN, THE TERMS “OFFSHORE TRANSACTION”, “UNITED STATES” AND “U.S. PERSON” HAVE THE MEANINGS GIVEN TO THEM BY REGULATION S UNDER THE SECURITIES ACT”.

Section 4.11 Ownership of Securities. Such Purchaser and its Affiliates do not, as of the date hereof, own five percent or more of the Company’s issued and outstanding capital stock.

Section 4.12 Company Information. Such Purchaser acknowledges and agrees that the Company has provided or made available to such Purchaser (through EDGAR at www.sec.gov , the Company’s website or otherwise) all Company SEC Documents, as well as all press releases issued by the Company through the date of this Agreement that are included in a filing by the Company on Form 8-K or clearly posted on the Company’s website.

ARTICLE V

COVENANTS

Section 5.1 Taking of Necessary Action. Each of the parties hereto shall use its commercially reasonable efforts promptly to take or cause to be taken all action and promptly to do or cause to be done all things necessary, proper or advisable under applicable Law and regulations to consummate and make effective the transactions between the Company and the Purchasers contemplated by this Agreement related specifically to the acquisition of the Purchased Shares. Without limiting the foregoing, each of the Company and each Purchaser shall use its commercially reasonable efforts to make all filings and obtain all consents of Governmental Authorities that may be necessary or, in the reasonable opinion of the other parties, as the case may be, advisable for the consummation of the transactions contemplated by the Operative Documents. Each Purchaser agrees that its trading activities, if any, with respect to Company’s securities will be in compliance with all applicable state and federal securities laws, rules and regulations. The Company shall promptly and accurately respond, and shall use its commercially reasonable efforts to cause its transfer agent to respond, to reasonable requests for information (which is otherwise not publicly available) made by a Purchaser or its auditors relating to the actual holdings of such Purchaser or its accounts; provided that, the Company shall not be obligated to provide any such information that could reasonably result in a violation of applicable law or conflict with the Company’s insider trading policy or a confidentiality obligation of the Company.

Section 5.2 Non-Public Information. On or before 9:30 a.m., Utah local time, on the Business Day immediately following the date hereof, the Company shall issue a press release (the “Press Release”) announcing the entry into this Agreement and describing the terms of the transactions contemplated by the Operative Documents and any other material, nonpublic information that the Company may have provided any Purchaser at any time prior to the issuance of the Press Release. On or before the fourth Business Day following the date hereof, the Company shall file a Current Report on Form 8-K with the Commission describing the terms of the transactions contemplated by the Operative Documents, and including as an exhibit to such Current Report on Form 8-K the Operative Documents, in the form required by the Exchange Act.

ARTICLE VI

INDEMNIFICATION

Section 6.1 Indemnification by the Company. The Company agrees to indemnify each Purchaser and its Representatives (collectively, “Purchaser Related Parties”) from costs, losses, liabilities, damages, or expenses of any kind or nature whatsoever, and hold each of them harmless against, any and all actions, suits, proceedings (including any investigations, litigation or inquiries), demands, and causes of action, and, in connection therewith, and promptly upon demand, pay or reimburse each of them for all costs, losses, liabilities, damages, or expenses of any kind or nature whatsoever, including, without limitation, the reasonable fees and disbursements of counsel and all other reasonable expenses incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted against or involve any of them as a result of, arising out of, or in any way related to the breach of any of the representations, warranties or covenants of the Company contained herein, provided that such claim for indemnification relating to a breach of the representations or warranties is made prior to the expiration of such representations or warranties to the extent applicable; and provided further, that no Purchaser Related Party shall be entitled to recover special, consequential or punitive damages under this Section 6.1.

Section 6.2 Indemnification by Purchasers. Each Purchaser agrees, severally and not jointly, to indemnify the Company and its respective Representatives (collectively, “Company Related Parties”) from, and hold each of them harmless against, any and all actions, suits, proceedings (including any investigations, litigation or inquiries), demands, and causes of action, and, in connection therewith, and promptly upon demand, pay or reimburse each of them for all costs, losses, liabilities, damages, or expenses of any kind or nature whatsoever, including, without limitation, the reasonable fees and disbursements of counsel and all other reasonable expenses incurred in connection with investigating, defending or preparing to defend any such matter that may be incurred by them or asserted against or involve any of them as a result of, arising out of, or in any way related to the breach of any of the representations, warranties or covenants of such Purchaser contained herein, provided that such claim for indemnification relating to a breach of the representations and warranties is made prior to the expiration of such representations and warranties; and provided further, that no Company Related Party shall be entitled to recover special, consequential or punitive damages.

Section 6.3 Indemnification Procedure. Promptly after any Company Related Party or Purchaser Related Party (hereinafter, the “Indemnified Party”) has received notice of any indemnifiable claim hereunder, or the commencement of any action, suit or proceeding by a third person, which the Indemnified Party believes in good faith is an indemnifiable claim under this Agreement, the Indemnified Party shall give the indemnitor hereunder (the “Indemnifying Party”) written notice of such claim or the commencement of such action, suit or proceeding, but failure to so notify the Indemnifying Party will not relieve the Indemnifying Party from any liability it may have to such Indemnified Party hereunder except to the extent that the Indemnifying Party is materially prejudiced by such failure. Such notice shall state the nature and the basis of such claim to the extent then known. The Indemnifying Party shall have the right to defend and settle, at its own expense and by its own counsel who shall be reasonably acceptable to the Indemnified Party, any such matter as long as the Indemnifying Party pursues the same diligently and in good faith. If the Indemnifying Party undertakes to defend or settle, it shall promptly notify the Indemnified Party of its intention to do so, and the Indemnified Party shall cooperate with the Indemnifying Party and its counsel in all commercially reasonable respects in the defense thereof and the settlement thereof. Such cooperation shall include, but shall not be limited to, furnishing the Indemnifying Party with any books, records and other information reasonably requested by the Indemnifying Party and in the Indemnified Party’s possession or control. Such cooperation of the Indemnified Party shall be at the cost of the Indemnifying Party. After the Indemnifying Party has notified the Indemnified Party of its intention to undertake to defend or settle any such asserted liability, and for so long as the Indemnifying Party diligently pursues such defense, the Indemnifying Party shall not be liable for any additional legal expenses incurred by the Indemnified Party in connection with any defense or settlement of such asserted liability; provided, however, that the Indemnified Party shall be entitled (i) at its expense, to participate in the defense of such asserted liability and the negotiations of the settlement thereof and (ii) if (A) the Indemnifying Party has failed to assume the defense or employ counsel reasonably acceptable to the Indemnified Party or (B) if the defendants in any such action include both the Indemnified Party and the Indemnifying Party and counsel to the Indemnified Party shall have concluded that there may be reasonable defenses available to the Indemnified Party that are different from or in addition to those available to the Indemnifying Party or if the interests of the Indemnified Party reasonably may be deemed to conflict with the interests of the Indemnifying Party, then the Indemnified Party shall have the right to select a separate counsel and to assume such legal defense and otherwise to participate in the defense of such action, with the expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the Indemnifying Party as incurred. Notwithstanding any other provision of this Agreement, the Indemnifying Party shall not settle any indemnified claim without the consent of the Indemnified Party, unless the settlement thereof imposes no liability or obligation on, and includes a complete release from liability of, and does not include any admission of wrongdoing or malfeasance by, the Indemnified Party. The remedies provided for in this Section 6 are cumulative and are not exclusive of any remedies that may be available to a party at law or in equity or otherwise.

ARTICLE VII

MISCELLANEOUS

Section 7.1 Interpretation and Survival of Provisions. Article, Section, Schedule, and Exhibit references are to this Agreement, unless otherwise specified. All references to instruments, documents, contracts, and agreements are references to such instruments, documents, contracts, and agreements as the same may be amended, supplemented, and otherwise modified from time to time, unless otherwise specified. The word “including” shall mean “including but not limited to.” Whenever any party has an obligation under the Operative Documents, the expense of complying with that obligation shall be an expense of such party unless otherwise specified. Whenever any determination, consent, or approval is to be made or given by any Purchaser, such action shall be in such Purchaser’s sole discretion unless otherwise specified in this Agreement. If any provision in the Operative Documents is held to be illegal, invalid, not binding, or unenforceable, such provision shall be fully severable and the Operative Documents shall be construed and enforced as if such illegal, invalid, not binding, or unenforceable provision had never comprised a part of the Operative Documents, and the remaining provisions shall remain in full force and effect. The Operative Documents have been reviewed and negotiated by sophisticated parties with access to legal counsel and shall not be construed against the drafter.

Section 7.2 Survival of Provisions. The representations, warranties, covenants and agreements contained in this Agreement shall survive the Closing for a period of twelve (12) months following the Closing Date regardless of any investigation made by or on behalf of the Company or any Purchaser. All indemnification obligations of the Company and the Purchasers pursuant to this Agreement and the provisions of Article VI shall remain operative and in full force and effect unless such obligations are expressly terminated in a writing by the parties, regardless of any purported general termination of this Agreement.

Section 7.3 No Waiver; Modifications in Writing.

(a) Delay. No failure or delay on the part of any party in exercising any right, power, or remedy hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, power, or remedy preclude any other or further exercise thereof or the exercise of any other right, power, or remedy. The remedies provided for herein are cumulative and are not exclusive of any remedies that may be available to a party at law or in equity or otherwise.

(b) Amendments and Waivers. Except as otherwise provided herein, no amendment, waiver, consent, modification, or termination of any provision of this Agreement or any other Operative Document shall be effective unless signed by each of the parties hereto or thereto affected by such amendment, waiver, consent, modification, or termination. Any amendment, supplement or modification of or to any provision of this Agreement or any other Operative Document, any waiver of any provision of this Agreement or any other Operative Document, and any consent to any departure by the Company from the terms of any provision of this Agreement or any other Operative Document shall be effective only in the specific instance and for the specific purpose for which made or given. Except where notice is specifically required by this Agreement, no notice to or demand on the Company in any case shall entitle the Company to any other or further notice or demand in similar or other circumstances.

Section 7.4 Binding Effect; Assignment.

(a) Binding Effect. This Agreement shall be binding upon the Company, the Purchasers, and their respective successors and permitted assigns. Except as expressly provided in this Agreement, this Agreement shall not be construed so as to confer any right or benefit upon any Person other than the parties to this Agreement and their respective successors and permitted assigns.

(b) Assignment of Rights. All or any portion of the rights and obligations of any Purchaser under this Agreement may be transferred by such Purchaser to any Affiliate of such Purchaser without the consent of the

Company by delivery of an agreement to be bound to the terms of this Agreement and a revised signature page. No portion of the rights and obligations of any Purchaser under this Agreement may be transferred by such Purchaser to a non-Affiliate without the written consent of the Company (which consent shall not be unreasonably withheld by the Company).

Section 7.5 Confidentiality. Notwithstanding anything herein to the contrary, to the extent that any Purchaser has executed or is otherwise bound by a confidentiality agreement in favor of the Company, such Purchaser shall continue to be bound by such confidentiality agreement.

Section 7.6 Communications. All notices and demands provided for hereunder shall be in writing and shall be given by registered or certified mail, return receipt requested, telecopy, air courier guaranteeing overnight delivery or personal delivery to the following addresses:

(a) If to any Purchaser:

To the respective address listed on the applicable signature page

(b) If to StrategaBiz, Inc.:

626 East 1820 North

Orem, Utah 84097

Attention: Bob Bench

with a copy to:

Carman Lehnhof Israelsen, LLP

299 South Main Street, Suite 1300

Salt Lake City, Utah 84111

Attention: J. Martin Tate

Email: mtate@clilaw.com

or to such other address as the Company or such Purchaser may designate in writing. All notices and communications shall be deemed to have been duly given: at the time delivered by hand, if personally delivered; when notice is sent to the sender that the recipient has read the message, if sent by electronic mail; upon actual receipt if sent by certified mail, return receipt requested, or regular mail, if mailed; when receipt acknowledged, if sent via facsimile; and upon actual receipt when delivered to an air courier guaranteeing overnight delivery.

Section 7.7 Removal of Legend. In connection with a sale of the Purchased Shares by a Purchaser in reliance on Rule 144, the applicable Purchaser or its broker shall deliver to the transfer agent and the Company a broker representation letter providing to the transfer agent and the Company any information the Company deems necessary to determine that the sale of the Purchased Shares is made in compliance with Rule 144, including, as may be appropriate, a certification that the Purchaser is not an Affiliate of the Company and regarding the length of time the Purchased Shares have been held. Upon receipt of such representation letter, the Company shall promptly direct its transfer agent to remove the notation of a restrictive legend in such Purchaser’s certificates evidencing the Purchased Shares or the book-entry account maintained by the transfer agent, including the legend referred to in Section 4.11, and the Company shall bear all costs associated therewith. After a registration statement under the Securities Act permitting the public resale of the Purchased Shares has become effective or any Purchaser or its permitted assigns have held the Purchased Shares for one year, if the book-entry account of such Purchased Shares still bears the notation of the restrictive legend referred to in Section 4.11, the Company agrees, upon request of the Purchaser or permitted assignee, to take all steps necessary to promptly effect the removal of the legend described in Section 4.11 from the Purchased Shares, and the Company shall bear all costs associated therewith, regardless of whether the request is made in connection with a sale or otherwise, so long as such Purchaser or its permitted assigns provide to the Company any information the Company deems reasonably necessary to determine that the legend is no longer required under the Securities Act or applicable state laws, including (if there is no such registration statement) a certification that the holder is not an Affiliate of the Company (and a covenant to inform the

Company if it should thereafter become an Affiliate and to consent to the notation of an appropriate restriction) and regarding the length of time the Purchased Shares have been held.

Section 7.8 Entire Agreement. This Agreement, the other Operative Documents and the other agreements and documents referred to herein are intended by the parties as a final expression of their agreement and intended to be a complete and exclusive statement of the agreement and understanding of the parties hereto in respect of the subject matter contained herein and therein. There are no restrictions, promises, warranties or undertakings, other than those set forth or referred to herein or the other Operative Documents with respect to the rights granted by the Company or any of its Affiliates or any Purchaser or any of its Affiliates set forth herein or therein. This Agreement, the other Operative Documents and the other agreements and documents referred to herein or therein supersede all prior agreements and understandings between the parties with respect to such subject matter.

Section 7.9 Governing Law. This Agreement, and all claims or causes of action (whether in contract or tort) that may be based upon, arise out of or relate to this Agreement or the negotiation, execution or performance of this Agreement (including any claim or cause of action based upon, arising out of or related to any representation or warranty made in or in connection with this Agreement), will be construed in accordance with and governed by the laws of the State of Delaware without regard to principles of conflicts of laws. Any action against any party relating to the foregoing shall be brought in any federal or state court of competent jurisdiction located within the State of Delaware, and the parties hereto hereby irrevocably submit to the non-exclusive jurisdiction of any federal or state court located within the State of Delaware over any such action. The parties hereby irrevocably waive, to the fullest extent permitted by applicable Law, any objection that they may now or hereafter have to the laying of venue of any such dispute brought in such court or any defense of inconvenient forum for the maintenance of such dispute. Each of the parties hereto agrees that a judgment in any such dispute may be enforced in other jurisdictions by suit on the judgment or in any other manner provided by Law.

Section 7.10 Execution in Counterparts. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which counterparts, when so executed and delivered, shall be deemed to be an original and all of which counterparts, taken together, shall constitute but one and the same Agreement.

Section 7.11 Termination

(a) Notwithstanding anything herein to the contrary, this Agreement shall automatically terminate at any time at or prior to the Closing if a statute, rule, order, decree or regulation shall have been enacted or promulgated, or if any action shall have been taken by any Governmental Authority of competent jurisdiction that permanently restrains, permanently precludes, permanently enjoins or otherwise permanently prohibits the consummation of the transactions contemplated by this Agreement or makes the transactions contemplated by this Agreement illegal.

(b) Notwithstanding anything herein to the contrary, this Agreement may be terminated at any time by any Purchaser (with respect to the obligations of such Purchaser) or the Company, upon written notice to the other party, if the Closing shall not have occurred on or before June 30, 2015 (the “Outside Date”); provided, however, that the right to terminate this Agreement under this Section 7.11(b) shall not be available to any party whose (i) breach of any provision of this Agreement, (ii) failure to comply with their obligations under this Agreement or (iii) actions not taken in good faith, shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to the Outside Date or the failure of a condition in Section 2.3 or Section 2.4 to be satisfied at such time;

(c) In the event of the termination of this Agreement as provided in this Section 7.11, (1) this Agreement shall forthwith become null and void and (2) there shall be no liability on the part of any party hereto, except as set forth in Article VI of this Agreement and except with respect to the requirement to comply with any confidentiality agreement in favor of the Company; provided that nothing herein shall relieve any party from any liability or obligation with respect to any willful breach of this Agreement.

Section 7.12 Recapitalization, Exchanges, Etc. Affecting the Common Stock. The provisions of this Agreement shall apply to the full extent set forth herein with respect to any and all equity interests of the Company or any successor or assign of the Company (whether by merger, consolidation, sale of assets or otherwise) which may be issued in respect of, in exchange for or in substitution of, the Common Stock, and shall be appropriately adjusted for combinations, recapitalizations and the like occurring after the date of this Agreement and prior to the Closing.

[Signature pages follow]

IN WITNESS WHEREOF, the parties hereto execute this Agreement, effective as of the date first above written.


STRATEGABIZ, INC.

By:
Name:		Brian Palm Svaneeng Mertz
Title:		CEO

Signature Page to

Common Stock Subscription Agreement

IN WITNESS WHEREOF, the parties hereto execute this Agreement, effective as of the date first above written.


[Purchaser]

By:
Name:
Title:
Number of Purchased Shares [_______] Aggregate Purchase Price USD [$ ] E-mail Address: Address: ____________________ ___________________________ ___________________________

Signature Page to

Common Stock Subscription Agreement[Missing Graphic Reference]

Schedule 1

Schedule of Purchasers

Exhibit A

The purchase of the Shares involves a high degree of risk including, but not necessarily limited to, the risks described below. Before subscribing for the Shares, the Purchaser should consider carefully the following risk factors, as well as the other information contained in the Agreement.

No Assurance of Success

There is no assurance that the Company’s activities will be profitable or that it will be able to meet its obligations. The Purchaser may lose all of its investment.

Past Performance Not a Predictor of Future Results

Past performance of the Company’s key personnel cannot be relied on to predict future success of the Company. The Company’s future performance is dependent on future events and is subject to a variety of factors not within the control of the Company, including, local and economic circumstances, availability of capital, and varying market conditions, and is therefore inherently uncertain.

No Operating History of Revenue and Minimal Assets Results in No Assurance of Success Which May Result in the Failure of the Business.

The Company has had no operating history nor any revenues or earnings from operations. The Company has no significant assets or financial resources. The Company will, in all likelihood, sustain operating expenses without corresponding revenues, at least until the consummation of a business combination. This may result in the Company incurring a net operating loss which will increase continuously until the Company can consummate a business combination with a profitable business opportunity. This may lessen the possibility of finding a suitable acquisition or merger candidate as such loss would be inherited on their financial statements. There is no assurance that the Company can identify such a business opportunity and consummate such a business combination.

Speculative Nature of Company’s Proposed Operations Results in No Assurance of Success Which May Result in the Failure of the Business.

The success of the Company's proposed plan of operation will depend to a great extent on the operations, financial condition and management of the identified business opportunity. While our officers and directors intend to seek business combinations with entities having established operating histories, there can be no assurance that the Company will be successful in locating candidates meeting such criteria. In the event the Company completes a business combination, of which there can be no assurance, the success of the Company's operations may be dependent upon management of the successor firm or venture partner firm and numerous other factors beyond the Company's control.

Scarcity of and Competition for Business Opportunities and Combinations May Scarcity of and Competition for Business Opportunities and Combinations May Limit Possible Business Combinations Which May Result in the Failure of the Business.

The Company is and will continue to be an insignificant participant in the business of seeking mergers with, joint ventures with and acquisitions of small private entities. A large number of established and well-financed entities, including venture capital firms, are active in mergers and acquisitions of companies which may be desirable target candidates for the Company. Nearly all such entities have significantly greater financial resources, technical expertise and managerial capabilities than the Company and, consequently, the Company will be at a competitive disadvantage in identifying possible business opportunities and successfully completing a business combination. Moreover, the Company will also compete in seeking merger or acquisition candidates with numerous other small public companies.

Since There is No Agreement For Business Combination or Other Transaction and No Standards for Business Combination the Purchaser May Not Approve the Transaction Which May Result in the Failure of the Business.

The Company has no arrangement, agreement or understanding with respect to engaging in a merger with, joint venture with or acquisition of, an entity. There can be no assurance the Company will be successful in identifying and evaluating suitable business opportunities or in concluding a business combination. Our sole officer and director has not identified any particular industry or specific business within an industry for evaluations. The Company has been in the start-up stage since inception and has no operations to date. Other than issuing shares to its original shareholder, the Company never commenced any operational activities. There is no assurance the Company will be able to negotiate a business combination on terms favorable to the Company. The Company has not established a specific length of operating history or a specified level of earnings, assets, net worth or other criteria which it will require a target business opportunity to have achieved, and without which the Company would not consider a business combination in any form with such business opportunity. It is a requirement under Rule 419(e) of the Securities Act that the net assets or fair market value of any business to be acquired must represent at least 80% of the maximum offering proceeds. The acquisition may be consummated through the use of the offering proceeds, loans or equity.

The Company’s Reporting Requirements May Delay or Preclude Acquisition Which May Result in the Failure of the Business.

The Company will be required to provide certain information about significant acquisitions, including certified financial statements for the company acquired, covering one or two years, depending on the relative size of the acquisition. The time and additional costs that may be incurred by some target entities to prepare such statements may significantly delay or essentially preclude consummation of an otherwise desirable acquisition by the Company. Acquisition prospects that do not have or are unable to obtain the required audited statements may not be appropriate for acquisition so long as the reporting requirements of the 1934 Act are applicable.

The Company’s Lack of Market Research or Marketing Organization May Limit Business Combinations Which May Result in the Failure of the Business.

The Company has neither conducted, nor have others made available to it, results of market research indicating that market demand exists for the transactions contemplated by the Company. Moreover, the Company does not have, and does not plan to establish, a marketing organization. Even in the event demand is identified for a merger or acquisition contemplated by the Company, there is no assurance the Company will be successful in completing any such business combination.

The Company’s Lack of Diversification May Limit Future Business Which May Result in the Failure of the Business.

The Company's proposed operations, even if successful, will in all likelihood result in the Company engaging in a business combination with only one business opportunity. Consequently, the Company's activities will be limited to those engaged in by the business opportunity which the Company merges with or acquires. The Company's inability to diversify its activities into a number of areas may subject the Company to economic fluctuations within a particular business or industry and therefore increase the risks associated with the Company's operations.

The Company May Fall Under Possible Investment Company Act Regulation Which May Increase Costs Which May Result in the Failure of the Business.

Although the Company will be subject to regulation under the Securities Exchange Act of 1933, our officers and directors believe the Company will not be subject to regulation under the Investment Company Act of 1940, insofar as the Company will not be engaged in the business of investing or trading in securities. In the event the Company engages in business combinations which result in the Company holding passive investment interests in a number of entities, the Company could be subject to regulation under the Investment Company Act of 1940. In such event, the Company would be required to register as an investment company and could be expected to incur significant registration and compliance costs. The Company has obtained no formal determination from the Securities and Exchange Commission as to the status of the Company under the Investment Company Act of 1940 and, consequently, any violation of such Act would subject the Company to material adverse consequences.

The Probable Change in Control And Management Upon a Business Combination May Result in Uncertain Management Future Which May Result in the Failure of the Business.

A business combination involving the issuance of the Company's common stock will, in all likelihood, result in shareholders of a private company obtaining a controlling interest in the Company. The resulting change in control of the Company could result in removal of the present officer and director of the Company and a corresponding reduction in or elimination of his participation in the future affairs of the Company.

The Reduction of Percentage Share Ownership Following a Business Combination May Result in Dilution.

The Company's primary plan of operation is based upon a business combination with a private concern which, in all likelihood, would result in the Company issuing securities to shareholders of such private company. The issuance of previously authorized and unissued common stock of the Company would result in reduction in percentage of shares owned by present and prospective shareholders of the Company and would most likely result in a change in control or management of the Company.

Dependence on Key personnel

The Company is dependent on the services of key personnel. The loss of the services of these personnel could have an adverse affect on the future operations of the Company.

Qualified personnel

The Company’s ability to realize its objectives shall be dependent on its ability to attract and retain qualified personnel. Competition for such personnel can be intense, and there can be no assurance that the Company’s results shall be able to attract and retain qualified personnel.

Protection of Intellectual Property

The Company’s success may be dependent in part on protecting its intellectual property, including trade secrets, confidential information and proprietary technology. Legal protection of such intellectual property may be unavailable and to the extent available, may not adequately protect such intellectual property or may be unenforceable against alleged infringers. Contractual provisions intended to protect such intellectual property may be breached. Despite precautions, unauthorized third parties may be able to copy aspects of the Company’s intellectual property and competitors may be able to independently design around legal protections.

Risks related to Technology

The Company cannot guarantee the successful development and utilization intellectual property which is acquired, either through an acquisition or development. In the event the Company is unable to successfully develop and utilize the technology related thereto, the value of the Purchaser’s investment may be adversely affected.

No Minimum Offering

There is no minimum aggregate principle amount of Shares that must be sold by the Company prior to the initial closing, and the Company expects to accept subscriptions for Shares as they are received. As a result, there can be no assurance that the Company shall raise sufficient funds in the Offering to carry out its business plan as currently proposed, or that the net proceeds from subscriptions shall be in an amount sufficient to enable the Company to continue operations in any meaningful manner.

We arbitrarily determined the price of the common stock we are offering.

We determined the offering price of the Shares we are offering. The offering price does not bear any direct relationship to the value of our physical assets, the book value of our common stock, or any other generally accepted criteria of valuation. The price and other terms were based on a number of factors including, without limitation, estimates of our business potential and earnings prospects and the consideration of such potential earnings in relation to market valuations of comparable companies. The offering price is not an indication of the actual value of our common stock at the time of this offering.

Furthermore, if a market for our common stock develops, the price of our common stock following this offering may be highly volatile as the securities of emerging businesses often are. Additionally, in recent years, the stock market has experienced a high level of price and volume volatility and market prices for the securities of many companies, particularly of small and emerging growth companies, the common stock of which trade in the over-the-counter market, have experienced wide price fluctuations which have not necessarily been related to the operating performance of these companies.

Need for Additional Financing

There can be no assurances that the Company shall be able to obtain additional funding when needed, or that such funding, if available, shall be available on terms acceptable to the Company. In the event the Company’s operations do not generate sufficient cash flow, or the Company cannot acquire additional funds if and when needed, the Company may be forced to curtail or cease its activities which likely would result in the loss to the Purchaser of all or a substantial portion of its investment.

Rule 144 Not Available

The Company is a “shell company” and as such, shareholders may not rely upon Rule 144 for the resale of the Company’s shares. Unless the Company registers the Shares or one year passes after the Company provides the information required under Form 10 and is current in all of its regulatory filings, the Shares will remain restricted and a shareholder will not be able to sell the Shares.

There is Only a Limited Public Trading Market for the Shares.

Purchasers may not be able to resell their Shares in the near future or possibly ever, and thus could lose all or part of their investment. The shares are listed on the OTC Bulletin Board under the symbol SGBZ. Listing on the OTC Bulletin Board does not constitute any endorsement or approval of a listed company or its securities, and the OTC Bulletin Board does not review or monitor an issuer’s activities. Our common stock is a “penny stock” (as defined in Exchange Act Rule 3a-51) which means that brokers can only buy or sell the common stock on an unsolicited basis. The penny stock rule and similar regulations will reduce the likelihood that a liquid trading market will arise for the common stock. The common stock may trade at less than the offering price. Because our stock is a “penny stock” a shareholder may find it more difficult to dispose of, or to obtain accurate quotations as to the price of, the Company’s common stock.

In the absence of a security being quoted on NASDAQ, or the Company having $2,000,000 in net tangible assets, trading in the Shares is covered by Rule 15c2-6 promulgated under the Securities Exchange Act of 1934 for non-NASDAQ and non-exchange listed securities. Under such rule, broker/dealers who recommend such securities to persons other than established customers and accredited Purchasers (generally institutions with assets in excess of $5,000,000 or individuals with a net worth in excess of $1,000,000 or an annual income exceeding $200,000 or $300,000 jointly with their spouse) must make a special written suitability determination for the purchaser and receive the purchaser's written agreement to a transaction prior to sale. Securities are also exempt from this rule if the market price is at least $5.00 per share, or for warrants, if the warrants have an exercise price of at least $5.00 per share.

The Securities Enforcement and Penny Stock Reform Act of 1990 requires additional disclosures related to the market for penny stocks and for trades in any stock defined as a penny stock. The Commission's regulations under such Act define a penny stock to be any NASDAQ or non-NASDAQ equity security that has a market price or exercise price of less than $5.00 per share and allow for the enforcement against violators of the proposed rules. In addition, unless exempt, the rules require the delivery, prior to any transaction involving a penny stock, of a disclosure schedule prepared by the Commission explaining important concepts involving the penny stock market, the nature of such market, terms used in such market, the broker/dealer's duties to the customer, a toll-free telephone number for inquiries about the broker/dealer's disciplinary history, and the customer's rights and remedies in case of fraud or abuse in the sale. Disclosure also must be made about commissions payable to both the broker/dealer and the registered representative, current quotations for the securities, and if the broker/dealer is the sole market-maker, the broker/dealer must disclose this fact and its control over the market. Finally, monthly statements must be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

While many NASDAQ stocks are covered by the proposed definition of penny stock, transactions in NASDAQ stock are exempt from all but the sole market-maker provision for (i) issuers who have $2,000,000 in tangible assets ($5,000,000 if the issuer has not been in continuous operation for three years), (ii) transactions in which the customer is an institutional accredited Purchaser and (iii) transactions that are not recommended by the broker/dealer. In addition, transactions in a NASDAQ security directly with the NASDAQ market-maker for such securities, are subject only to the sole market-maker disclosure, and the disclosure with regard to commissions to be paid to the broker/dealer and the registered representatives.

Absence of Merit Review

No state of federal authority has reviewed the accuracy or adequacy of the information contained herein nor has any regulatory authority made a merit review of the Offering or the terms of the Note offered to the Purchaser. Therefore, the Purchaser must therefore judge for itself the adequacies of the disclosures, the pricing and fairness of the terms of the Offering.

Regulation S

A portion of the Shares are being offered pursuant to an exemption from registration under Regulation S. Regulation S provides an exclusion from the Section 5 registration requirements of the Securities Act for offerings made outside the United States by both U.S. and foreign issuers. Regulation S is available only for “offers and sales of securities outside the United States” made in good faith and not as a means of circumventing the registration provisions of the Securities Act. The availability of the issuer (Rule 903) and the resale (Rule 904) safe harbors is contingent on two general conditions (a) the offer or sale must be made in an offshore transaction; and (b) no “directed selling efforts” may be made by the issuer, a distributor, any of their respective affiliates, or any person acting on their behalf.

The Shares will initially be restricted as described under “Book-entry, Delivery and Form” for a period ending six month after the closing date. Before any interest in the Shares may be offered, sold, pledged or otherwise transferred to a purchaser outside the United States in compliance with Rule 904 under the Securities Act, the transferor will be required to provide the fiscal agent with a written certificate (the form of which certification can be obtained from the fiscal agent) as to compliance with the transfer restriction referred to above.

Forward-Looking Statements

The Disclosure Materials contain certain forward-looking statements regarding the plans and objectives of management for future operations, including plans and objectives relating to the development of the Company’s business. The forward-looking statements included herein are based on current expectations and assumptions that involve numerous risks and uncertainties. Although the Company believes that its assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate. As a result, there can be no assurance that the forward-looking statements included in this Agreement shall prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by the Company or any other entity that the objectives and plans of the Company shall be achieved.

The foregoing list of risk factors does not purport to be complete and does not describe all of the risks relating to an investment in the Company. Some of the other risks of an investment in the Company are nor foreseen or fully discernable, understood or recognizable by the Company. Purchasers should read the Disclosure Materials and consult with their own legal and financial advisers before investing in the Company.

Delaware		84-1089377
(State or other jurisdiction of		(I.R.S. Employer
incorporation or organization)		Identification No.)

626 East 1820 North
Orem, Utah		84097
(Address of principal executive offices)		(Zip Code)

Large accelerated filer o	Accelerated filer o
Non-accelerated filer o (Do not check if a smaller reporting company)	Smaller reporting company x

		Page
PART I


Item 1.	Business	5
Item 1A.	Risk Factors	6
Item 1B.	Unresolved Staff Comments	6
Item 2.	Properties	6
Item 3.	Legal Proceedings	6
Item 4	Mine Safety Disclosure	7

PART II

Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	7
Item 6.	Selected Financial Data	11
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	11
Item 7A.	Quantitative and Qualitative Disclosures About Market Risk	13
Item 8.	Financial Statements and Supplementary Data	14
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	14
Item 9A.	Controls and Procedures	14
Item 9B.	Other Information	15

PART III

Item 10.	Directors, Executive Officers and Corporate Governance	16
Item 11.	Executive Compensation	19
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	21
Item 13.	Certain Relationships and Related Transactions, and Director Independence	21
Item 14.	Principal Accounting Fees and Services	23
PART IV
Item 15.	Exhibits and Financial Statement Schedules	24
	SIGNATURES	25
	FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA	F-1

Fiscal year ended June 30, 2015	High			Low

Fourth quarter		$	4.75		$	3.50
Third quarter		$	7.00		$	1.75
Second quarter		$	3.60		$	1.75
First quarter		$	3.35		$	2.40

Fiscal year ended June 30, 2014	High			Low

Fourth quarter		$	6.00		$	2.40
Third quarter		$	13.20		$	3.00
Second quarter		$	22.50		$	10.50
First quarter		$	21.00		$	6.00


Plan category	Number of securities to be issued upon exercise of outstanding options, warrants and rights		Weighted-average exercise price of outstanding options, warrants and rights		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a))
	(a)		(b)		(c)

Equity compensation plans
approved by security holders		0	$	0		110,000

Equity compensation plans not approved by security holders		0	$	0		-

Total		0	$	0		110,000

•	pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
•	provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles in the United States, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and
•	provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Name	Age	Position
Brian Mertz	40	Chief Executive Officer and Director
Robert K. Bench	66	President and Chief Financial Officer
Soren Jonassen	47	Director, Chairman
Ole Sigetty	46	Director

Person	Year	Salary ($)		Bonus ($)		Stock Awards ($)		Option Awards ($)		Non-equity Incentive Comp ($)		All Other Comp. ($)		Total ($)

Brian Mertz (1)	2015	$	-		-		-		-		-	$	116,667	$	116,667
Robert K. Bench (1)	2015	$	154,000		-		-		-		-	$	0	$	154,000
Robert K. Bench (1)	2014	$	28,000		-		-		-		-	$	5,400	$	33,400

	Quarterly		Face to Face Mtg.		Telephonic Mtg.
Board Chairman	$	4,000	$	1,500	$	750
Board Member	$	3,000	$	1,000	$	500
Committee Chair			$	500	$	250
Committee Member			$	400	$	200

	Upon Election (1)	Annual Refresh (2)
Board Chairman	40,000 options	7,000 options
Board Member	30,000 options	6,000 options

	Amount and Nature of				Percent of Class of
Name and Address	Beneficial Ownership (1)				Common Stock
Brian Mertz, CEO and Director		2,266,667	(2	)	58.92	%
626 East 1820 North
Orem, Utah 84097

Stephen Abu		251,326	(3	)	6.53	%
626 East 1820 North
Orem, Utah 84097

Robert Bench, President and CFO		29,457	(4	)	0.77	%
626 East 1820 North
Orem, Utah 84097

Ole Sigetty, Director		66,667			1.73	%
626 East 1820 North
Orem, Utah 84097

Soren Jonassen, Director		75,529			1.96	%
Hvedevej 4
2765 Smorum, Denmark

All current executive officers and
directors as a group (4 persons)		2,438,320			63.38	%

	2015		2014
Audit	$	39,500	$	35,400
Tax	$	10,775	$	6,825
Consultation	$	0	$	1,517
Total	$	50,275	$	43,767

Exhibit No.	Description and method of filing

3.1	Certificate of Incorporation of BayHill Capital Corporation, dated April 24, 2008 (incorporated by reference to Exhibit 99.5 to Form 8-K filed on April 30, 2008).

3.2	Certificate of Amendment of Certificate of Incorporation Registrant, filed on March 19, 2012. (incorporated by reference to Exhibit 3.3 to Form 8-K filed on April 5, 2012).

3.3	Bylaws of BayHill Capital Corporation, as adopted on May 12, 2008 (incorporated by reference to Exhibit 3.1 to Form 10-KSB filed on May 14, 2008) PREVIOUSLY FILED EXHIBITS 10.1 THRU 10.55 ARE EXCLUDED HERE AS NO LONGER MATERIAL OR RELEVANT. SUCH EXHIBITS REMAIN ON FILE AND ARE AVAILABLE FROM THE COMPANY.

10.56	Subscription Agreement dated August 20, 2014 by and between the Company and World Wide Investment Fund, Ltd. (Filed as Exhibit 10.56 to the Company’s Annual Report on Form 10-K filed on October 20, 2015.

10.57	Subscription Agreement dated October 2, 2014 by and between the Company and World Wide Investment Fund, Ltd. (Filed as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on October 8, 2014 and incorporated herein by reference)

10.58	Subscription Agreement dated October 2, 2014 by and between the Company and Stratega ApS. (Filed as Exhibit 10.2 to the Company’s Form 8-K filed with the Securities and Exchange Commission on October 8, 2014 and incorporated herein by reference)

10.59	Subscription Agreement dated October 2, 2014 by and between the Company and Brian Mertz. (Filed as Exhibit 10.3 to the Company’s Form 8-K filed with the Securities and Exchange Commission on October 8, 2014 and incorporated herein by reference)

10.60	Subscription Agreement dated February 23, 2015 by and between the Company and certain purchasers. (File as Exhibit 10.1 to the Company’s Form 8-K filed with the Securities and Exchange Commission on February 23, 2015 and incorporated herein by reference)

10.61	Subscription Agreement Dated Jun 30, 2015 by and between the Company and certain purchasers.

14.1	Code of Business Conduct and Ethics, adopted May 12, 2008 (filed as Exhibit 14.1 to Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission for the year ended June 30, 2008, filed September 12 and incorporated by reference).

31.1	Certification of Principal Executive Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a))

31.2	Certification of Principal Financial Officer of Registrant pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (Rule 13a-14(a) or Rule 15d-14(a))

32.1	Certification of Principal Executive Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2	Certification of Principal Financial Officer pursuant to 18 U.S.C. 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

99.1	Press Release dated September 1, 2015 (Filed as Exhibit 99.1 to the Company’s form 8-K filed with the Securities and Exchange Commission on September 1, 2015 and incorporated herein by reference)


Date: September 30, 2015	CryptoSign Inc., a Delaware corporation
	/S/ Robert K. Bench
	Robert K. Bench, President, Chief Financial Officer

Date:	September 30, 2015	/S/ Brian Mertz
		Brian Mertz Chief Executive officer and Director

Date:	September 30, 2015	/S/ Soren Jonassen
		Soren Jonassen, Director

Date:	September 30, 2015	/S/ Ole Sigetty
		Ole Sigetty, Director

	June 30, 2015			June 30, 2014
ASSETS
Current Assets
Cash	$	2,306		$	3,628
Prepaid expenses		10,500			-
Subscriptions receivable		393,750			-
Notes receivable		-			128,657
Total current assets		406,556			132,285


Total Assets	$	406,556		$	132,285

LIABILITIES AND STOCKHOLDERS' DEFICIT
Current Liabilities
Accounts payable	$	31,672		$	8,503
Accounts payable, related parties		11,901			-
Accrued liabilities		6,652			206,207
Notes payable, related parties		65,000			115,787
Total current liabilities		115,225			330,497

Total Liabilities	$	115,225		$	330,497

Commitments and Contengiencies
STOCKHOLDERS' EQUTY (DEFICIT)
Preferred stock, $.0001 par value, 400,000 shares authorized; no shares
issued and outstanding		-			-
Common stock $.0001 par value, 100,000,000 shares authorized;
3,847, 236 shares issued and outstanding at June 30, 2015 and
1,088,667 shares issued and outstanding at June 30, 2014		385			109
Additional paid-in capital		6,889,818			5,577,675
Accumulated deficit		(6,598,872	)		(5,775,996	)
Total stockholders' equity (deficit)		291,331			(198,212	)

Total Liabilities and Stockholders' Deficit	$	406,556		$	132,285

CRYPTOSIGN INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Years Ended June 30,
	2015			2014
Operating Expenses:
Selling, general and administrative	$	(804,488	)	$	(2,658,712	)
Total Operating Expenses		(804,488	)		(2,658,712	)

Loss from Operations		(804,488	)		(2,658,712	)

Other Income and Expense:
Interest income		2,931			21,196
Interest expense		(21,319	)		(104,825	)
Total Other Income and Expense		(18,388	)		(83,629	)

Loss from continuing operations		(822,876	)		(2,742,341	)
Loss from discontinued operations		-			(756,270	)
Net Loss	$	(822,876	)	$	(3,498,611	)

Basic and diluted loss per common share
From continuing operations	$	(0.28	)	$	(4.56	)
From discontinued operations		-			(1.27	)
Total	$	(0.28	)	$	(5.83	)

Basic and diluted weighted average number of common shares outstanding		2,942,468			601,160

CRYPTOSIGN INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

									Additional
	Preferred Stock				Common Stock				Paid-in		Accumulated
	Shares		Amount		Shares		Amount		Capital		Deficit			Total
Balance at June 30, 2013		-	$	-		623,529	$	62	$	2,036,130	$	(2,277,385	)	$	(241,193	)

Issuance of stock for cash		-		-		33,333		3		24,997		-			25,000
Issuance of stock for settlement of liabilities		-		-		273,205		27		838,808		-			838,835
Issuance of stock related to sale of ASHG		-		-		158,500		16		665,684		-			665,700
Share-based compensation from issuance of options
and stock		-		-		-		-		1,638,666		-			1,638,666
Stock expense for settlement in stock in excess of
liability		-		-		-		-		373,391		-			373,391
Net loss		-		-		-		-		-		(3,498,611	)		(3,498,611	)

Balance at June 30, 2014		-		-		1,088,568		109		5,577,675		(5,775,996	)		(198,212	)

Issuance of stock for cash		-		-		2,337,000		234		486,766		-			487,000
Issuance of stock for subscriptions receivable		-		-		175,000		18		393,733		-			393,750
Issuance of stock for payment of expenses		-		-		46,667		5		81,663		-			81,667
Issuance of stock for Compensation		-		-		200,001		20		349,982		-			350,002
Net loss		-		-		-		-		-		(822,876	)		(822,876	)

Balance at June 30, 2015		-	$	-		3,847,236	$	385	$	6,889,818	$	(6,598,872	)	$	291,331

CRYPTOSIGN INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS

	For the Years Ended June 30,
	2015			2014
Cash Flows From Operating Activities
Net loss	$	(822,876	)	$	(3,498,611	)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation		350,002			1,638,666
Stock issued for expenses		81,667			-
Stock expense for settlement in stock in excess of liability		-			373,391
Accretion of debt discount		-			44,424
Depreciation		-			3,648
Bad debt expense-notes receivable		-			50,833
Impairment of land under capital lease		-			257,414
Changes in operating assets and liabilities:
Prepaid expenses		(10,500	)		-
Accounts payable		23,169			432,390
Accounts payable, related parties		11,901			(54,031	)
Accrued liabilities		(199,555	)		562,430
Net Cash Used in Operating Activities		(566,192	)		(189,446	)

Cash Flows From Investing Activities
Principal payments on notes receivable		128,657			98,804
Net Cash Provided by Investing Activities		128,657			98,804

Cash Flows From Financing Activities
Proceeds from issuance of common stock for cash		487,000			125,000
Principal payments on unsecured notes payable, related parties		(115,787	)		(17,500	)
Proceeds from issuance of unsecured notes payable, related parties		65,000			-
Principal payments on secured convertible notes payable, related parties		-			(18,000	)
Net Cash Provided by Financing Activities		436,213			89,500

Net Decrease in Cash		(1,322	)		(1,142	)
Cash at Beginning of Period		3,628			4,770
Cash at End of Period	$	2,306		$	3,628

Supplemental Disclosures of Cash Flow Information:
Noncash Investing and Financing activities:
Conversion of accounts payable and accrued liabilities to notes payable	$	-		$	476,926

	Page

Report of Independent Registered Public Accounting Firm	F-2

Consolidated Financial Statements:

Consolidated Balance Sheets as of June 30, 2015 and 2014	F-3

Consolidated Statements of Operations for the Years Ended
June 30, 2015 and 2014	F-4

Consolidated Statements of Stockholders’ Deficit for the
Years Ended June 30, 2015 and 2014	F-5

Consolidated Statements of Cash Flows for the Years Ended
June 30, 2015 and 2014	F-6

Notes to Consolidated Financial Statements	F-7

	June 30,		June 30,
Note Holder	2015		2014
Brian Mertz	$	65,000	$	-
ClearWater Law and Governace Group, LLC		-		32,001	*
James U Jensen		-		25,954	*
Robert K Bench		-		29,546	*
Robyn Farnsworth		-		28,286
Total	$	65,000	$	115,787

*Secured with all Company assets

Nature and Amount of Liability

	Accounts		Accrued		Accrued		Notes		Total		Number
Name	Payable		Interest		Liabilities		Payable		liabilities		of shares
Stephen Abu	$	116,609	$	-	$	-	$	-	$	116,609		116,667
Robert Bench		-		6,450		-		190,455		196,905		46,574
Alan Kronborg		-		-		60,000		60,000		120,000		30,038
Clearwater Law Group		-		2,795		-		48,001		50,796		12,731
Robyn Farnsworth		-		2,613		-		42,430		45,043		11,289
Rene Mikkelsen		-		1,353		3,500		36,462		41,315		10,355
James Jensen		-		2,272		4,500		33,305		40,077		10,049
Soren Jonassen		-		1,109		3,500		30,754		35,363		8,863
Peter Moller		20,000		-		-		-		20,000		6,667
Lars Nielsen		-		3,323		-		75,780		79,103		5,274
Peter Opata		-		120		3,500		8,000		11,620		2,912
John Thomas		-		2,715		-		6,000		8,715		2,184
John Knab		-		2,489		-		5,500		7,989		2,002
Andrew Goodman		6,500		-		-		-		6,500		1,504
Totals	$	143,109	$	25,239	$	75,000	$	536,687	$	780,035		267,109

Note 8 - Stockholder's Equity (Details) - USD ($)		1 Months Ended					2 Months Ended			12 Months Ended
Note 8 - Stockholder's Equity (Details) - USD ($)	Dec. 28, 2014	Dec. 31, 2015	Jun. 30, 2015	Dec. 31, 2014	Oct. 31, 2014	Aug. 31, 2014	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Dec. 15, 2015	Dec. 27, 2014	Dec. 14, 2014	Jun. 20, 2014
Common Stock, shares authorized			100,000,000							100,000,000	100,000,000
Common Stock, par or stated value			$ 0.0001							$ 0.0001	$ 0.0001
Common Stock, shares outstanding			3,847,236							3,847,236	1,088,667	3,288,280		98,660,002
Preferred Stock, shares authorized			400,000							400,000	400,000
Preferred Stock, par or stated value			$ 0.0001							$ 0.0001	$ 0.0001
Issuance of stock for cash, Value			$ 393,750		$ 300,000	$ 50,000		$ 137,000		$ 487,000	$ 25,000
Issuance of stock for settlement of liabilities, Value											838,835
Value of Issuance of stock related to sale of ASHG											665,700
Stockholders' Equity, Reverse Stock Split										1 for 30 reverse stock split
Issuance of stock for payment of expenses, Value										$ 81,667
Allocated Share-based Compensation Expense		$ 150,001					$ 50,000			$ 350,002
Hugo Svaneeng Holdings ApS
Issuance of stock for payment of expenses, Value	$ 81,667
Affiliated Entity
Issuance of stock for settlement of liabilities, Value											$ 780,035
Common Stock
Issuance of stock for cash, Shares			175,000		1,885,714	314,252		137,000		2,337,000	33,333
Issuance of stock for cash, Value										$ 234	$ 3
Issuance of stock for settlement of liabilities, Shares											273,205
Issuance of stock for settlement of liabilities, Value											$ 27
Issuance of stock related to sale of ASHG, Shares											158,500
Share Price			$ 1.75							$ 1.75	$ 4.20		$ 0.75		$ 4.20
Value of Issuance of stock related to sale of ASHG											$ 16
Issuance of stock for payment of expenses, Shares										46,667
Issuance of stock for payment of expenses, Value										$ 5
Issuance of stock for payment of expenses, Shares				200,001					66,667
Common Stock \| Hugo Svaneeng Holdings ApS
Issuance of stock for payment of expenses, Shares	46,667
Common Stock \| Settlement of liabilities with present and past affiliates of the Company
Issuance of stock for settlement of liabilities, Shares											267,108

Note 2 - Going Concern (Details) - USD ($)	12 Months Ended
Note 2 - Going Concern (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Details
Net loss	$ (822,876)	$ (3,498,611)
Accumulated deficit	(6,598,872)	(5,775,996)
Net Cash Used in Operating Activities	(566,192)	$ (189,446)
Working Capital	$ 291,331

Note 6 - Settlement of Liabilities (Details) - USD ($)	12 Months Ended
Note 6 - Settlement of Liabilities (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014	Dec. 27, 2014	Jun. 20, 2014
Share-based compensation	$ 350,002	$ 1,638,666
Stock expense for settlement in stock in excess of liability		373,391
Adjustment To Additional Paid In Capital Fair Value Of Liabilities in Excess of Common Stock Issued		58,431
Affiliated Entity
Share-based compensation		$ 400,249
Common Stock
Issuance of stock for settlement of liabilities, Shares		273,205
Share Price	$ 1.75	$ 4.20	$ 0.75	$ 4.20
Share-based compensation, stock issued	200,001
Common Stock \| Affiliated Entity
Share-based compensation, stock issued		26,858
Common Stock \| Settlement of liabilities with present and past affiliates of the Company
Issuance of stock for settlement of liabilities, Shares		267,108

Note 5 - Secured And Unsecured Notes Payable To Related Parties: Schedule of Secured And Unsecured Notes Payable to Related Parties (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014	Jun. 20, 2014
Notes payable, related parties	$ 65,000	$ 115,787	$ 536,687
Brian Mertz
Notes payable, related parties	65,000	0
ClearWater Law and Governance Group, LLC
Notes payable, related parties	0	32,001	48,001
James U Jensen
Notes payable, related parties	0	25,954	33,305
Robert K. Bench
Notes payable, related parties	0	29,546	190,455
Robyn Farnsworth
Notes payable, related parties	$ 0	$ 28,286	$ 42,430

Note 6 - Settlement of Liabilities: Schedule of Settlement Of Liabilities (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014	Jun. 20, 2014	Jun. 30, 2013
Accounts payable, related parties	$ 11,901		$ 143,109
Accrued liabilities	6,652	$ 206,207	75,000
Notes Payable	65,000	115,787	536,687
Total Liabilities	115,225	330,497	780,035
Settlement of liabilities with present and past affiliates of the Company
Accounts payable, related parties			143,109
Accured Interest			25,239
Accrued liabilities			75,000
Notes Payable			536,687
Total Liabilities			780,035
Stephen Abu
Accounts payable, related parties			116,609
Accured Interest			0
Accrued liabilities			0
Notes Payable			0
Total Liabilities			116,609
Robert K. Bench
Accounts payable, related parties			0
Accured Interest			6,450
Accrued liabilities			0
Notes Payable	0	29,546	190,455
Total Liabilities			196,905
Alan Kronborg
Accounts payable, related parties			0
Accured Interest			0
Accrued liabilities			60,000
Notes Payable			60,000
Total Liabilities			120,000
ClearWater Law and Governance Group, LLC
Accounts payable, related parties			0
Accured Interest			2,795
Accrued liabilities			0
Notes Payable	0	32,001	48,001
Total Liabilities			50,796
Robyn Farnsworth
Accounts payable, related parties			0
Accured Interest			2,613
Accrued liabilities			0
Notes Payable	0	28,286	42,430
Total Liabilities			45,043
Rene Mikkelsen
Accounts payable, related parties			0
Accured Interest			1,353
Accrued liabilities			3,500
Notes Payable			36,462
Total Liabilities			41,315
James U Jensen
Accounts payable, related parties			0
Accured Interest			2,272
Accrued liabilities			4,500
Notes Payable	$ 0	$ 25,954	33,305
Total Liabilities			40,077
Soren Jonassen
Accounts payable, related parties			0
Accured Interest			1,109
Accrued liabilities			3,500
Notes Payable			30,754
Total Liabilities			35,363
Peter Moller
Accounts payable, related parties			20,000
Accured Interest			0
Accrued liabilities			0
Notes Payable			0
Total Liabilities			20,000
Lars Nielsen
Accounts payable, related parties			0
Accured Interest			3,323
Accrued liabilities			0
Notes Payable			75,780
Total Liabilities			79,103
Peter Opata
Accounts payable, related parties			0
Accured Interest			120
Accrued liabilities			3,500
Notes Payable			8,000
Total Liabilities			11,620
John D Thomas
Accounts payable, related parties			0
Accured Interest			2,715
Accrued liabilities			0
Notes Payable			6,000
Total Liabilities			8,715
John M Knab
Accounts payable, related parties			0
Accured Interest			2,489
Accrued liabilities			0
Notes Payable			5,500
Total Liabilities			7,989
Andrew Goodman
Accounts payable, related parties			6,500
Accured Interest			0
Accrued liabilities			0
Notes Payable			0
Total Liabilities			$ 6,500
Common Stock
Number of shares	3,847,236	1,088,568	267,109	623,529
Common Stock \| Settlement of liabilities with present and past affiliates of the Company
Number of shares			267,109
Common Stock \| Stephen Abu
Number of shares			116,667
Common Stock \| Robert K. Bench
Number of shares			46,574
Common Stock \| Alan Kronborg
Number of shares			30,038
Common Stock \| ClearWater Law and Governance Group, LLC
Number of shares			12,731
Common Stock \| Robyn Farnsworth
Number of shares			11,289
Common Stock \| Rene Mikkelsen
Number of shares			10,355
Common Stock \| James U Jensen
Number of shares			10,049
Common Stock \| Soren Jonassen
Number of shares			8,863
Common Stock \| Peter Moller
Number of shares			6,667
Common Stock \| Lars Nielsen
Number of shares			5,274
Common Stock \| Peter Opata
Number of shares			2,912
Common Stock \| John D Thomas
Number of shares			2,184
Common Stock \| John M Knab
Number of shares			2,002
Common Stock \| Andrew Goodman
Number of shares			1,504

Note 7 - Discontinued Operations (Details) - USD ($)	12 Months Ended
Note 7 - Discontinued Operations (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014	Dec. 27, 2014	Jun. 20, 2014
Value of Issuance of stock related to sale of ASHG		$ 665,700
Loss from discontinued operations	$ 0	(756,270)
Sale of Subsidiary Gain (Loss)
Loss from discontinued operations		86,822
Common Stock
Value of Issuance of stock related to sale of ASHG		$ 16
Issuance of stock related to sale of ASHG, Shares		158,500
Share Price	$ 1.75	$ 4.20	$ 0.75	$ 4.20

CONSOLIDATED BALANCE SHEETS - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Current Assets
Cash	$ 2,306	$ 3,628
Prepaid expenses	10,500
Subscriptions receivable	393,750
Notes receivable		128,657
Total current assets	406,556	132,285
Total Assets	406,556	132,285
Current Liabilities
Accounts payable	31,672	8,503
Accounts payable, related parties	11,901
Accrued liabilities	6,652	206,207
Notes payable, related parties	65,000	115,787
Total current liabilities	115,225	330,497
Total Liabilities	$ 115,225	$ 330,497
Commitments and Contengiencies
STOCKHOLDERS' EQUTY (DEFICIT)
Preferred stock, $.0001 par value, 400,000 shares authorized; no shares issued and outstanding
Common stock $.0001 par value, 100,000,000 shares authorized; 3,847, 236 shares issued and outstanding at June 30, 2015 and 1,088,667 shares issued and outstanding at June 30, 2014	$ 385	$ 109
Additional paid-in capital	6,889,818	5,577,675
Accumulated deficit	(6,598,872)	(5,775,996)
Total stockholders' equity (deficit)	291,331	(198,212)
Total Liabilities and Stockholders' Deficit	$ 406,556	$ 132,285

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Cash Flows From Operating Activities
Net loss	$ (822,876)	$ (3,498,611)
Adjustments to reconcile net loss to net cash used in operating activities:
Share-based compensation	350,002	1,638,666
Stock issued for expenses	81,667
Stock expense for settlement in stock in excess of liability		373,391
Accretion of debt discount		44,424
Depreciation		3,648
Bad debt expense-notes receivable		50,833
Impairment of land under capital lease		257,414
Changes in operating assets and liabilities:
Prepaid expenses	(10,500)
Accounts payable	23,169	432,390
Accounts payable, related parties	11,901	(54,031)
Accrued liabilities	(199,555)	562,430
Net Cash Used in Operating Activities	(566,192)	(189,446)
Cash Flows From Investing Activities
Principal payments on notes receivable	128,657	98,804
Net Cash Provided by Investing Activities	128,657	98,804
Cash Flows From Financing Activities
Proceeds from issuance of common stock for cash	487,000	125,000
Principal payments on unsecured notes payable, related parties	(115,787)	(17,500)
Proceeds from issuance of unsecured notes payable, related parties	65,000
Principal payments on secured convertible notes payable, related parties		(18,000)
Net Cash Provided by Financing Activities	436,213	89,500
Net Decrease in Cash	(1,322)	(1,142)
Cash at Beginning of Period	3,628	4,770
Cash at End of Period	2,306	3,628
Noncash Investing and Financing activities:
Conversion of accounts payable and accrued liabilities to notes payable		476,926
Shares issued to pay principal and accrued interest of secured convertible notes payable		58,800
Shares issued to sale Agricon SH Ghana		665,700
Shares issued for settlement of liabilities		838,835
Shares issued for subscriptions receivable	393,750
Cash paid for interest	$ 13,319	$ 9,544

Note 10 - Income Taxes (Details) - USD ($)	12 Months Ended
Note 10 - Income Taxes (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Operating Losses relating to Domestic Operations	$ 822,876	$ 2,829,163
Operating Losses relating to Foreign Operations	0	669,448
Net Operating Loss Carryforwards	6,467,305	7,240,785
Loss from Operations	$ (804,488)	(2,658,712)
Percentage change of ownership during the period	50.00%
GHANA
Loss from Operations	$ 0	(1,869,348)
Minimum
Operating Loss Carryforwards, Expiration Date	Dec. 31, 2032
Internal Revenue Service (IRS)
Net Operating Loss Carryforwards	$ 2,540,382	1,945,797
NOL Carryforwards to Become Permanently Restricted	0
State and Local Jurisdiction
Net Operating Loss Carryforwards	3,926,923	$ 3,425,640
NOL Carryforwards to Become Permanently Restricted	$ 1,274,626

Note 10 - Income Taxes: Deferred income tax assets, temporary differences and carry forwards (Details) - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Details
Accrued compensation	$ 22,380	$ 43,189
Debt Discount & Beneficial conversion on debt	0	(4,075)
Other	0	6,516
Net operating loss carry forwards	993,318	774,617
Valuation allowance	(1,015,698)	(820,247)
Deferred Tax Assets, Net of Valuation Allowance, Total	$ 0	$ 0

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Jun. 30, 2015	Jun. 30, 2014
Statement Of Financial Position
Common Stock, par or stated value	$ 0.0001	$ 0.0001
Common Stock, shares authorized	100,000,000	100,000,000
Common Stock, shares issued	3,847,236	1,088,667
Common Stock, shares outstanding	3,847,236	1,088,667
Preferred Stock, par or stated value	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized	400,000	400,000
Preferred Stock, shares issued
Preferred Stock, shares outstanding

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Jun. 30, 2015	Sep. 30, 2015	Dec. 31, 2014
Document And Entity Information
Entity Registrant Name	STRATEGABIZ, INC.
Entity Central Index Key	0000726293
Document Type	10-K
Document Period End Date	Jun. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--06-30
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Smaller Reporting Company
Entity Public Float			$ 2,405,603
Entity Common Stock, Shares Outstanding		3,847,236
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2015
Trading Symbol	cpsn
Entity Information, Date to Change Former Legal or Registered Name	Jun. 18, 2015

Note 3 - Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jun. 30, 2015
Policies
Use of Estimates	*Use of Estimates* – The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure on contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates include estimated future value of leased properties, realizability of notes receivable, and realizability of deferred tax assets. Actual results could differ from those estimates.
Business Condition	*Business Condition* – The Company discontinued all business activities on June 20, 2014 and as of June 30, 2015 was a “shell corporation” under SEC regulations. The Company has begun to look for operating companies or other business opportunities to acquire. The ability of the Company to continue as a going concern is dependent on the success of that plan. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern (see Note 2—Going Concern).
Cash	*Cash*–The balance in cash consists of cash reserves held in checking accounts.
Notes Receivable	*Notes Receivable* – The Company had one note receivable, which arose from the sale of Commission River, a prior subsidiary. The note was paid during the year ended June 30, 2015. See further discussion and disclosure in Note 4.
Subscriptions Receivable	*Subscriptions Receivable* – The Company recognizes subscriptions receivable as an asset when the cash is received subsequent to the balance sheet date but prior to the filing of the financial statements. See further discussion and disclosure in Note 11.
Income Taxes	*Income Taxes* – The Company accounts for income taxes pursuant to Accounting Standards Codification (ASC) 740, Income Taxes, which requires the use of the asset and liability method of accounting for deferred income taxes. We recognize deferred tax liabilities and assets based on the differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements that will result in taxable or deductible amounts in future years. All allowances against deferred income tax assets are recorded in whole or in part, when it is more likely than not those deferred income tax assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is required to the extent it is more-likely-than-not that a deferred tax asset will not be realized. ASC 740 also requires reporting of taxes based on tax positions that meet a more-likely-than-not standard and are measured at the amount that is more-likely-than-not to be realized. Differences between financial and tax reporting which do not meet this threshold are required to be recorded as unrecognized tax benefits. ASC 740 also provides guidance on the presentation of tax matters and the recognition of potential IRS interest and penalties. The Company classifies penalty and interest expense related to income tax liabilities as an income tax expense. The Company did not recognize interest or penalties in the consolidated statements of operations for the years ended June 30, 2015 and 2014 and no accrued interest or penalties are included in the consolidated balance sheets as of June 30, 2015 and 2014. See further discussion and disclosures in Note 10.
Basic and Diluted Loss Per Share	*Basic and Diluted Loss Per Share* – Basic loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period giving no effect to potentially dilutive issuable common shares. As of June 30, 2015 the Company had no options or potentially issuable shares outstanding.
Share-based Compensation	*Share-Based Compensation* – The Company recognizes compensation expense for share-based awards expected to vest on a straight-line basis over the requisite service period of the award based on their grant date fair value. The Company estimates the fair value of stock options using a lattice model that values the options based on probability weighted projections of the various potential outcomes. The intrinsic value, stock performance, stock volatility, vesting or exercise factors, and forfeiture variables, are all considerations under this model. If stock grants are related to a future performance condition, the Company recognizes compensation expense when the performance condition, leading to the issuance, becomes probable of occurring.
Recently Enacted Accounting Standards	*Recently Enacted Accounting Standards* – In June 2014, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update No. 2014-10, Development Stage Entities and Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Consolidation (“ASU 2014-10”), which removed the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from U.S. generally accepted accounting principles. In addition, the amendments eliminated the requirements for development stage entities to: (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance for risks and uncertainties is applicable to entities that have not yet commenced planned principal operations. The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements pertaining to development stage entities are to be applied retrospectively. The amendments related to the disclosure of risks and uncertainties are to be applied prospectively. ASU 2014-10 is effective for the Company for annual reporting periods beginning July 1, 2015, and for the interim periods therein, with early application of each of the amendments permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued. As a result, management adopted ASU 2014-10 as of June 30, 2014, and the effects of the adoption are reflected in the accompanying financial statements and related notes. As described above, the adoption of ASU 2014-10 eliminated certain disclosures of information formerly required of development stage entities, including inception-to-date information in the accompanying statements of operations, cash flows, and stockholders’ deficit. The adoption of ASU 2014-10 also combined the amounts of deficit accumulated during the development stage and prior to the development stage into one amount for accumulated deficit in stockholders’ deficit. The elimination of these disclosure requirements had no other effect on the amounts reported for total assets, liabilities, stockholders’ deficit, net loss, or loss per common share. In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (“ASU 2014-09”), which stipulates that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, an entity should apply the following steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. ASU 2014-09 will be effective for the Company retrospectively beginning July 1, 2017, with early adoption not permitted. Management is currently evaluating the impact of the pending adoption of ASU 2014-09 on the Company’s financial statements.

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	Jun. 30, 2015	Jun. 30, 2014
Operating Expenses:
Selling, general and administrative	$ (804,488)	$ (2,658,712)
Total Operating Expenses	(804,488)	(2,658,712)
Loss from Operations	(804,488)	(2,658,712)
Other Income and Expense:
Interest income	2,931	21,196
Interest expense	(21,319)	(104,825)
Total Other Income and Expense	(18,388)	(83,629)
Loss from continuing operations	(822,876)	(2,742,341)
Loss from discontinued operations	0	(756,270)
Net Loss	$ (822,876)	$ (3,498,611)
Basic and diluted loss per common share
From continuing operations	$ (0.28)	$ (4.56)
From discontinued operations		(1.27)
Total	$ (0.28)	$ (5.83)
Basic and diluted weighted average number of common shares outstanding	2,942,468	601,160

Note 9 - Share Based Compensation (Details) - USD ($)	1 Months Ended		2 Months Ended		12 Months Ended
Note 9 - Share Based Compensation (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 30, 2015	Dec. 27, 2014	Jun. 30, 2014	Jun. 20, 2014
Allocated Share-based Compensation Expense	$ 150,001		$ 50,000		$ 350,002
Common Stock
Issuance of stock for payment of expenses, Shares		200,001		66,667
Share Price					$ 1.75	$ 0.75	$ 4.20	$ 4.20

Note 4 - Notes Receivable (Details) - Commission River Corporation - USD ($)	12 Months Ended
	Jun. 30, 2015	Aug. 31, 2010
Debt Instrument, Face Amount		$ 490,000
Debt Instrument, Interest Rate, Stated Percentage	6.00%
Debt Instrument, Frequency of Periodic Payment	monthly
Required monthly payments	$ 10,000

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Stockholders' Equity, beginning of period, Value at Jun. 30, 2013	$ 62	$ 2,036,130	$ (2,277,385)	$ (241,193)
Stockholders' Equity, beginning of period, Shares at Jun. 30, 2013	623,529
Issuance of stock for cash, Value	$ 3	24,997		25,000
Issuance of stock for cash, Shares	33,333
Issuance of stock for settlement of liabilities, Value	$ 27	838,808		838,835
Issuance of stock for settlement of liabilities, Shares	273,205
Issuance of stock related to sale of ASHG, Value	$ 16	665,684		665,700
Issuance of stock related to sale of ASHG, Shares	158,500
Share-based compensation from issuance of options and stock		1,638,666		1,638,666
Stock expense for settlement in stock in excess of liability		373,391		373,391
Net loss			(3,498,611)	(3,498,611)
Stockholders' Equity, end of period, Value at Jun. 30, 2014	$ 109	5,577,675	(5,775,996)	(198,212)
Stockholders' Equity, end of period, Shares at Jun. 30, 2014	1,088,568
Issuance of stock for cash, Value	$ 234	486,766		487,000
Issuance of stock for cash, Shares	2,337,000
Issuance of stock for subscriptions receivable, Value	$ 18	393,733		393,750
Issuance of stock for subscriptions receivable, Shares	175,000
Issuance of stock for payment of expenses, Value	$ 5	81,663		81,667
Issuance of stock for payment of expenses, Shares	46,667
Issuance of stock for Compensation, Value	$ 20	349,982		350,002
Issuance of stock for Compensation, Shares	200,001
Net loss			(822,876)	(822,876)
Stockholders' Equity, end of period, Value at Jun. 30, 2015	$ 385	$ 6,889,818	$ (6,598,872)	$ 291,331
Stockholders' Equity, end of period, Shares at Jun. 30, 2015	3,847,236